142 related articles for article (PubMed ID: 23064458)
1. Prevalence of ΔF508 mutation in the cystic fibrosis transmembrane conductance regulator gene among cystic fibrosis patients from a Brazilian referral center.
Bieger AM; Marson FA; Bertuzzo CS
J Pediatr (Rio J); 2012; 88(6):531-4. PubMed ID: 23064458
[TBL] [Abstract][Full Text] [Related]
2. Frequency of the deltaF508 mutation in 108 cystic fibrosis patients in Sao Paulo: comparison with reported Brazilian data.
Okay TS; Oliveira WP; Raiz-Júnior R; Rodrigues JC; Del Negro GM
Clinics (Sao Paulo); 2005 Apr; 60(2):131-4. PubMed ID: 15880249
[TBL] [Abstract][Full Text] [Related]
3. ΔF508 mutation screening of healthy individuals from two populations in Espírito Santo State, Brazil.
Lanes AM; Louro LS; Ventorim DP; Stur E; Garcia FM; Agostini LP; Alves LN; Reis RS; Louro ID; Dettogni RS
Genet Mol Res; 2016 Dec; 15(4):. PubMed ID: 28002612
[TBL] [Abstract][Full Text] [Related]
4. Cystic fibrosis transmembrane conductance regulator gene mutations and glutathione S-transferase null genotypes in cystic fibrosis patients in Brazil.
Lima CS; Ortega MM; Marson FA; Zulli R; Ribeiro AF; Bertuzzo CS
J Bras Pneumol; 2012; 38(1):50-6. PubMed ID: 22407040
[TBL] [Abstract][Full Text] [Related]
5. Effect of genotype on phenotype and mortality in cystic fibrosis: a retrospective cohort study.
McKone EF; Emerson SS; Edwards KL; Aitken ML
Lancet; 2003 May; 361(9370):1671-6. PubMed ID: 12767731
[TBL] [Abstract][Full Text] [Related]
6. Cystic fibrosis gene variability in two southern Brazilian Amerindian populations: analysis of the deltaF508 mutation and the KM19 and XV2C haplotypes.
Raskin S; Petzl-Erler ML; Phillips JA; Pereira-Ferrari L; Probst CM; Faucz FR; Sotomaior V; Salzano FM; Culpi L
Hum Biol; 2007 Feb; 79(1):79-91. PubMed ID: 17985657
[TBL] [Abstract][Full Text] [Related]
7. Cystic fibrosis Δf508 mutation screening in Brazilian women with altered fertility.
Brunoro GV; Wolfgramm EV; Louro ID; Degasperi II; Busatto VC; Perrone AM; Batitucci MC
Mol Biol Rep; 2011 Oct; 38(7):4343-6. PubMed ID: 21110105
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of deltaF508, G551D, G542X, and R553X mutations among cystic fibrosis patients in the North of Brazil.
Araújo FG; Novaes FC; Santos NP; Martins VC; Souza SM; Santos SE; Ribeiro-dos-Santos AK
Braz J Med Biol Res; 2005 Jan; 38(1):11-5. PubMed ID: 15665983
[TBL] [Abstract][Full Text] [Related]
9. Molecular temporal bone pathology: III. Genotyping of the deltaF508 deletion in the DNA of patients with cystic fibrosis.
Wackym PA; Kerner MM; Grody WW
Laryngoscope; 1998 Aug; 108(8 Pt 2 Suppl 88):1-3. PubMed ID: 9707259
[TBL] [Abstract][Full Text] [Related]
10. Cystic fibrosis transmembrane conductance regulator mutations at a referral center for cystic fibrosis.
Coutinho CA; Marson FA; Ribeiro AF; Ribeiro JD; Bertuzzo CS
J Bras Pneumol; 2013; 39(5):555-61. PubMed ID: 24310628
[TBL] [Abstract][Full Text] [Related]
11. Molecular analysis in Brazilian cystic fibrosis patients reveals five novel mutations.
Bernardino AL; Ferri A; Passos-Bueno MR; Kim CE; Nakaie CM; Gomes CE; Damaceno N; Zatz M
Genet Test; 2000; 4(1):69-74. PubMed ID: 10794365
[TBL] [Abstract][Full Text] [Related]
12. A low prevalence of cystic fibrosis in Uruguayans of mainly European descent.
Cardoso H; Crispino B; Mimbacas A; Cardoso ME
Genet Mol Res; 2004 Jun; 3(2):258-63. PubMed ID: 15266396
[TBL] [Abstract][Full Text] [Related]
13. Towards preimplantation diagnosis of cystic fibrosis using microarrays.
Salvado CS; Trounson AO; Cram DS
Reprod Biomed Online; 2004 Jan; 8(1):107-14. PubMed ID: 14759297
[TBL] [Abstract][Full Text] [Related]
14. Low frequency of the deltaAF508 mutation of the CFTR gene in a highly admixed population in Bahia, Brazil.
Moura Costa FM; Santana MA; Lemos AC; Galvão-Castro B; Acosta AX
Hum Biol; 2007 Jun; 79(3):293-7. PubMed ID: 18078202
[TBL] [Abstract][Full Text] [Related]
15. Genotype-phenotype relationship for five CFTR mutations frequently identified in western France.
Duguépéroux I; De Braekeleer M;
J Cyst Fibros; 2004 Dec; 3(4):259-63. PubMed ID: 15698945
[TBL] [Abstract][Full Text] [Related]
16. CF gene and cystic fibrosis transmembrane conductance regulator expression in autosomal dominant polycystic kidney disease.
Persu A; Devuyst O; Lannoy N; Materne R; Brosnahan G; Gabow PA; Pirson Y; Verellen-Dumoulin C
J Am Soc Nephrol; 2000 Dec; 11(12):2285-2296. PubMed ID: 11095651
[TBL] [Abstract][Full Text] [Related]
17. Frequency of 8 CFTR gene mutations in cystic fibrosis patients in Minas Gerais, Brazil, diagnosed by neonatal screening.
Perone C; Medeiros GS; del Castillo DM; de Aguiar MJ; Januário JN
Braz J Med Biol Res; 2010 Feb; 43(2):134-8. PubMed ID: 20098842
[TBL] [Abstract][Full Text] [Related]
18. CFTR mutations in three Latin American countries.
Restrepo CM; Pineda L; Rojas-Martínez A; Gutiérrez CA; Morales A; Gómez Y; Villalobos MC; Borjas L; Delgado W; Myers A; Barrera-Saldaña HA
Am J Med Genet; 2000 Apr; 91(4):277-9. PubMed ID: 10766983
[TBL] [Abstract][Full Text] [Related]
19. Cystic fibrosis transmembrane regulator (CFTR) DeltaF508 mutation and 5T allele in patients with chronic pancreatitis and exocrine pancreatic cancer. PANKRAS II Study Group.
Malats N; Casals T; Porta M; Guarner L; Estivill X; Real FX
Gut; 2001 Jan; 48(1):70-4. PubMed ID: 11115825
[TBL] [Abstract][Full Text] [Related]
20. Cystic fibrosis in Uruguay.
Luzardo G; Aznarez I; Crispino B; Mimbacas A; Martínez L; Poggio R; Zielenski J; Tsui LC; Cardoso H
Genet Mol Res; 2002 Mar; 1(1):32-8. PubMed ID: 14963811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
